New Delhi, Aug 28 (PTI) Leading contract research firm Vivo Bio Tech on Saturday said it has signed a long-term supply contract with vaccine maker Biological E.

The value of the contract is estimated to be in the range of Rs 20 crore to Rs 30 crore per year, for each of the next three years, Vivo Bio Tech said in a regulatory filing.

Also Read | Creative Entrepreneur Mahmoud Shehada's Journey From a Finance Expert to Becoming a Content Creator.

Hyderabad-based Vivo Bio Tech is a full-service CRO (contract research organisation) offering drug development and discovery services to pharmaceutical and biotech companies worldwide. HRS hrs

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)